Acridine carboxamide
Chemical compound
From Wikipedia, the free encyclopedia
Acridine carboxamide is a chemotherapy agent that is being studied in the treatment of cancer. It belongs to the family of drugs called topoisomerase inhibitors.[citation needed]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H19N3O |
| Molar mass | 293.370 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
While the agent was well tolerated in Phase II clinical trials, it did not show efficacy when tested against various types of cancers.[1][2][3][4]
See also
- Ondansetron, an isomer of Acridine carboxamide